4D Molecular Therapeutics Inc (FDMT) Price Prediction & ForecastFDMT4D Molecular Therapeutics Inc

Alphio's FDMT stock price prediction model matches the current 4D Molecular Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.88 (-0.60%). The 1-week path is $11.63 (-2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, 4D Molecular Therapeutics Inc is not a strong buy due to its low RSI of 37.91, indicating potential oversold conditions, and a forward P/E ratio of 0, suggesting uncertainty in future earnings. However, the stock has shown a year-to-date change of +55.05%, indicating strong performance this year. The main risk is the significant net income loss reported in the latest quarter, amounting to -68.76 million USD, which raises concerns about the company's profitability moving forward.

4D Molecular Therapeutics Inc (FDMT) last closed at $11.9499998, gaining +5.29%. These facts feed the 1-day and 1-week FDMT price prediction above.